review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1365-2133.2010.09981.X |
P698 | PubMed publication ID | 20716209 |
P50 | author | Dusko Ilic | Q56768774 |
John Mcgrath | Q72104357 | ||
P2093 | author name string | A Petrova | |
P2860 | cites work | Disease-specific induced pluripotent stem cells | Q24641981 |
Virus-free induction of pluripotency and subsequent excision of reprogramming factors | Q24644686 | ||
Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors | Q28749672 | ||
Induced pluripotent stem cells from a spinal muscular atrophy patient | Q29614340 | ||
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes | Q29614341 | ||
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts | Q29614794 | ||
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 | Q29617098 | ||
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells | Q29619409 | ||
Generation of human induced pluripotent stem cells from dermal fibroblasts | Q34588555 | ||
Multipotent hair follicle stem cells promote repair of spinal cord injury and recovery of walking function | Q46078284 | ||
Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type | Q47933679 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | recessive dystrophic epidermolysis bullosa | Q7302398 |
P304 | page(s) | 1149-1156 | |
P577 | publication date | 2010-11-04 | |
P1433 | published in | British Journal of Dermatology | Q4970191 |
P1476 | title | Stem cell therapies for recessive dystrophic epidermolysis bullosa | |
P478 | volume | 163 |
Q37649276 | Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix |
Q37873887 | Concise review: Transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa |
Q45871193 | Correction of dog dystrophic epidermolysis bullosa by transplantation of genetically modified epidermal autografts |
Q38695955 | Human amniotic membrane grafts in therapy of chronic non-healing wounds |
Q53143040 | Management of severe epidermolysis bullosa by haematopoietic transplant: principles, perspectives and pitfalls. |
Q26865551 | Molecular therapeutics for heritable skin diseases |
Q36610899 | Novel molecular therapies for heritable skin disorders |
Q37707008 | Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa |
Q38510204 | Recessive dystrophic epidermolysis bullosa: a review of disease pathogenesis and update on future therapies. |
Q38692453 | Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant. |
Search more.